S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung-Reference-Cited by-同舟云学术

S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung

Published:2023-03 Issue:3 Volume:13 Page:1110-1127
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Hao Mengyao^ORCID,Fu Rong,Tai Jun,Tian Zhenhuan,Yuan Xia,Chen Yang^ORCID,Wang Mingjin,Jiang Huimin,Ji Ming^ORCID,Lai Fangfang^ORCID,Xue Nina,Bai Liping^ORCID,Zhu Yizhun,Lv Xiaoxi,Chen Xiaoguang,Jin Jing^ORCID

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference83 articles.

1. Fibroblast-enriched endoplasmic reticulum protein TXNDC5 promotes pulmonary fibrosis by augmenting TGFβ signaling through TGFBR1 stabilization;Lee;Nat Commun,2020

2. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis;Wollin;Eur Respir J,2015

3. Pathogenesis of idiopathic pulmonary fibrosis;Wolters;Annu Rev Pathol,2014

4. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis;Phan;Cell Mol Life Sci,2021

5. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials;Noble;Lancet,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective Activation of GPCRs: Molecular Dynamics Investigation of Siponimod’s Interaction with S1PR1 and S1PR2;2024-07-11

2. Forsythoside A regulates pulmonary fibrosis by inhibiting endothelial-to-mesenchymal transition and lung fibroblast proliferation via the PTPRB signaling;Phytomedicine;2024-07

3. Sphingolipids: drivers of cardiac fibrosis and atrial fibrillation;Journal of Molecular Medicine;2023-11-28